The Cancer Genetics Program is designed to increase knowledge in the area of hereditary cancer genetics. This slide-based, expert-led course provides a comprehensive collection on an array of topics related to the genetic cancer risk assessment process. The course addresses ways to improve the taking and documenting of family history, as well as interpreting those results. The program is composed of site-specific sections on core concepts that include recognition of hereditary cancer syndromes, quantitative risk assessment, establishing a cancer risk assessment service, and special counseling and ethical, legal, and social issues in cancer genetics.
- Recognize genetic testing for common cancer syndromes and how to interpret Variants of Unknown Significance (VUS)
- Consider the emergent strategies and the latest advances in early detection cancers (breast, GI, etc.)
- Analyze genome wide association studies (GWAS) and principles of next generation technology in tumor/germline DNA and gene panels
- Summarize key learnings from each core section and utilize approaches to improve the process of recognition and referral of hereditary cancer syndromes within physician practices
Continuing Education Credit
10 Credits/Points are available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- ABIM MOC Points
- ABMS MOC Points for Pathology (ABP) and Radiology (ABR)
- CNE Contact Hours
- ONCC ILNA Points in Screening/Early Detection and Scientific Basis/Diagnosis
- CPE Credits
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.
- This course expires on April 20, 2019. Participants must complete all necessary course components by this date to receive credit.